DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Firms / G••••• H••••• I••••••••• A•••••••• L••
G••••• H••••• I••••••••• A•••••••• L••
Investing in a H•••••ier and Safer World. Global H••••• Investment Corporation (GHIC) is a nonprofit organization catalyzing the development of technologies to improve human health worldwide.
Classification
- Class
- Buyout firmprobable, confidence 65%
- Basis
- R6: 1 of 1 distinct vehicles are sworn Private Equity Funds; 1 reported gross assets on a filing in 2022 or later
- Size band
- Lower middle marketdefined by: proxy: $0.09bn Private Equity Fund GAV on the Form ADV filed 2023-08-23
Classification history (1)
- Sep 13, 2026Buyout firm (probable, 65%, cls-pe-1)R6: 1 of 1 distinct vehicles are sworn Private Equity Funds; 1 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
- Adviser type
- exempt reporting adviser
- Form ADV filings
- Oct 12, 2016 to Aug 23, 2023
- RAUM
- unknownregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 1
- PE fund GAV, latest filing
- $88.6Mreported gross assets (Form ADV), not fund size
- All private fund GAV
- $88.6Mevery private fund type, latest filing
- 2024 PE fund GAV
- unknownsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2023-08-23, latest gav Private Equity Fund $88.6M, latest counts Private Equity Fund 1, lifetime distinct Private Equity Fund 1
- Employees
- unknown
- Business phone
- 917 363 2788
Stated criteria beside observed behaviour
31 observed deals
Stated by the firm
- Sectors
- technology
- Geography
- Global
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- "We invest in global health because we know that when health improves, life improves by every measure." – Bill Gates, Chair, Gates Foundation
Observed from deals on record
- roles
- unknown 30, platform 1
- period
- to 2026-05-20, from 2026-05-20, undated holdings 30, dated observations 2
- window
- last 2026-05-20, first 2026-05-20
- control
- control 1, unknown 30
- companies
- 31
- geography
- investments
- 31
- seller kinds
- transactions
- 1
- cadence by year
- 2026 platforms 1
- platform add on
- add ons 0, platforms 1, add ons per platform unknown
- sector known for
- 3
- disclosed value usd
- n 0
- sector distribution
- count 1, share 0.032, value industrial manufacturing, examples Antheia, count 1, share 0.032, value life sciences, examples Aerska, count 1, share 0.032, value healthcare it, examples Verge H•••••Tech Fund II
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 1, share 0.032, value miscellaneous manufacturing, examples Antheia, count 1, share 0.032, value life sciences, examples Aerska, count 1, share 0.032, value healthcare it, examples Verge H•••••Tech Fund II
31 companies on the graph (1 transactions); most in industrial manufacturing (1); 1 platforms and 0 add-ons; observed 2026 to 2026
Funds
1 on record
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| G••••• H••••• I••••••••• F••• I• ADV: Private Equity Fund | buyout or unlabelled | unknown | $88.6M as of Aug 23, 2023 | no Form D | Harvest |
Team
1 current, 1 former
Partner (1)
- C••• H• L•••••• · Member · since Jun 1, 2015 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
1 former (kept with end dates)
- G•••• A•••••• R•••••• · Member · Jun 1, 2015 to Mar 30, 2020 Inference
Portfolio
31 relationships, 1 platforms, 0 add-ons
Transactions
2 on record
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| May 20, 2026 | Platform acquisition | A••••• | Sponsor (confirmed) | ghicfunds.org |
| Jul 24, 2025 | Exit to a strategic buyer | V•••• H••••••••• F••• I• | Seller (confirmed) | ghicfunds.org |
Placement agents, lenders, advisers and co-investors
0 relationships
No counterparty collected yet. These are counted from transactions that name both this firm and the other party, and from placement agents on this firm’s funds.
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
11 most recent
- Sep 1, 2026Adviser CRD 285306 is not on the SEC registered or exempt adviser roster of 2026-09-01
- May 26, 2026May 26 2026 Lilly to Acquire V•••••• C••••••, a Portfolio Company of GHIC’s Global H••••• Security Fund Read article
- May 20, 2026GHIC Announces $10M Investment in A••••• to Advance Systemic Delivery of RNA Medicines to the BrainPlatform investmentFactA•••••Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- May 20, 2026May 20 2026 GHIC Announces $10M Investment in A••••• to Advance Systemic Delivery of RNA Medicines to the Brain Read article
- Feb 3, 2026Feb 3 2026 GHIC Invests in P••••••• as Company Secures $20M Series A and $20M BARDA Contract to Advance Precision D••••••••• and Therapeutics Read article
- Nov 20, 2025Nov 20 2025 GHIC’s Catalytic H••••• Investment Platform and BlueMark Announce Partnership to Strengthen Impact Capabilities of Fund Managers Accelerating H•••••care Innovation in Low- and Middle-Income Countries Read article
- Jul 24, 2025GHIC invests in V•••• H••••••••• F••• I• through the Catalytic H••••• Investment Platform
- Jul 24, 2025Jul 24 2025 GHIC invests in V•••• H••••••••• F••• I• through the Catalytic H••••• Investment Platform Read article
- Apr 22, 2025Apr 22 2025 B•••••• Closes $100M Series C Financing to Advance Its Biowearable Platform Read article
- Oct 10, 2024Oct 10 2024 GHIC Invests in C•••••••’s $100M Series D to Accelerate Commercial Expansion of its Rapid Sepsis Solution Read article
- Oct 12, 2016G••••• H••••• I••••••••• A•••••••• L•• first filed Form ADV in the extract (ERA)